1-1 of 1
Stehpen M. Gottschalk, MD
Close
Sort by
Journal Articles

Genetically Modified Her2 -Specific T Cells Recognize Low and High Her 2 Expressing Breast Cancer Cells.

Nabil M. Ahmed, MD, MSc, Maheshika Ratnayake, Martin Pule, MD, Cliona M. Rooney, PhD, Helen E. Heslop, MD, Stehpen M. Gottschalk, MD
Journal: Blood
Blood (2005) 106 (11): 5540.
https://doi.org/10.1182/blood.V106.11.5540.5540
Published: 2005